Log in
NASDAQ:ELOS

436894 Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume562,777 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
436894 logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.89 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:ELOS
CUSIPN/A
Phone+972-7-32442200
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive ELOS News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











436894 (NASDAQ:ELOS) Frequently Asked Questions

What stocks does MarketBeat like better than 436894?

Wall Street analysts have given 436894 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 436894 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were 436894's earnings last quarter?

436894 (NASDAQ:ELOS) issued its quarterly earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 EPS for the quarter, topping the Zacks' consensus estimate of $0.06 by $0.03. The medical equipment provider had revenue of $75 million for the quarter, compared to the consensus estimate of $75.72 million. The business's revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.07 earnings per share.
View 436894's earnings history
.

What other stocks do shareholders of 436894 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 436894 investors own include Micron Technology (MU), Advanced Micro Devices (AMD), BIOLASE (BIOL), Cisco Systems (CSCO), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Lannett (LCI), Rite Aid (RAD), Ambarella (AMBA) and Citigroup (C).

Who are 436894's key executives?

436894's management team includes the following people:
  • Shimon Eckhouse Ph.D., Chairman of the Board
  • Amit Meridor, Chief Executive Officer
  • , Bio & Compensation - 
  • Hugo Goldman, Chief Financial Officer
  • , Bio & Compensation - 
  • Erik Dowell, Vice President-North America
  • William Griffing, Chief Executive Officer - Syneron Candela North America
  • Shlomo Alkalay, Chief Operating Officer
  • Lisa A. Soderquist, Chief Human Resource Officer
  • , Bio & Compensation - 
  • Robert Ruck, Executive Vice President, Asia Pacific
  • Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
  • Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy

What is 436894's stock symbol?

436894 trades on the NASDAQ under the ticker symbol "ELOS."

What is 436894's official website?

The official website for 436894 is syneron-candela.com.

How can I contact 436894?

436894's mailing address is Tavor Building 4 P.O. Box 550, YOKNEAM, 2069200, Israel. The medical equipment provider can be reached via phone at +972-7-32442200.

This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.